COMPOSITION PHARMACEUTIQUE PERMETTANT D'AMÉLIORER LES NIVEAUX DE FER DANS LE SANG, COMPRENANT DU POLYMALTOSE DE FER (III) ET UNE AUTRE SUBSTANCE ACTIVE ADAPTÉE À L'ABSORPTION DU FER CHOISIE PARMI LE FOLINATE DE CALCIUM PENTAHYDRATÉ, LA VITAMINE C OU UNE COMBINAISON DES DEUX
The invention relates to a pharmaceutical composition comprising iron (III) polymaltose complex and one active ingredient selected from calcium folinate pentahydrate, vitamin C or a combination of both, wherein the active ingredients are stored separately in a container consisting of a cylindrical bottle and a closure storage cap, wherein iron (III) polymaltose stored in the form of an oral solution in the bottle and calcium folinate pentahydrate or vitamin C or the combination of them is stored separately in a sealed manner in solid form in the closure storage cap. The container is properly configured to allow the mixing of two substances just prior to use, forming a single dose oral solution. The pharmaceutical composition helps the increase of iron levels in the blood and the anemia treatment in pregnancy and lactation.
